Last updated: May 7, 2025
Sponsor: Meir Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
empiric antibiotic therapy
Clinical Study ID
NCT05924126
MMC-0155-23
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients admitted to the general ICU due to sepsis or septic shock between 1/1/20 and 31/12/20
Exclusion
Exclusion Criteria: Patients who were admitted due to other non-infectious etiologies
Study Design
Total Participants: 155
Treatment Group(s): 1
Primary Treatment: empiric antibiotic therapy
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
September 30, 2025
Connect with a study center
Meir Medical Center
Kfar Saba,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.